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Abstract
Background Intramuscular fatty inﬁltration is generally associated with the accumulation of white adipocytes in skeletal
muscle and unfavourable metabolic outcomes. It is, however, still unclear whether intramuscular adipocytes could also acquire
a brown-like phenotype. Here, we detected intramuscular expression of brown adipocyte markers during fatty inﬁltration in an
obesity-resistant mouse strain and extensively compared the potential of two different stem cell populations residing in
skeletal muscle to differentiate into brown-like adipocytes.
Methods Fatty inﬁltration was induced using intramuscular glycerol or cardiotoxin injection in the tibialis anterior muscles of
young or aged 129S6/SvEvTac (Sv/129) mice or interleukin-6 (IL-6) knockout mice, and the expression of general and brown
adipocyte markers was assessed after 4 weeks. Fibro/adipogenic progenitors (FAPs) and myogenic progenitors were
prospectively isolated using ﬂuorescence-activated cell sorting from skeletal muscle of male and female C57Bl6/6J and
Sv/129 mice, and monoclonal and polyclonal cultures were treated with brown adipogenic medium. Additionally, FAPs were
differentiated with medium supplemented or not with triiodothyronine.
Results Although skeletal muscle expression of uncoupling protein 1 (Ucp1) was barely detectable in uninjected tibialis
anterior muscle, it was drastically induced following intramuscular adipogenesis in Sv/129 mice and further increased in
response to beta 3-adrenergic stimulation. Intramuscular Ucp1 expression did not depend on IL-6 and was preserved in aged
skeletal muscle. Myogenic progenitors did not form adipocytes neither in polyclonal nor monoclonal cultures. Fibro/
adipogenic progenitors, on the other hand, readily differentiated into brown-like, UCP1+ adipocytes. Uncoupling protein 1 ex-
pression in differentiated FAPs was regulated by genetic background, sex, and triiodothyronine treatment independently of
adipogenic differentiation levels.
Conclusions Intramuscular adipogenesis is associated with increased Ucp1 expression in skeletal muscle from obesity-
resistant mice. Fibro/adipogenic progenitors provide a likely source for intramuscular adipocytes expressing UCP1 under con-
trol of both genetic and hormonal factors. Therefore, FAPs constitute a possible target for therapies aiming at the browning of
intramuscular adipose tissue and the metabolic improvement of skeletal muscle affected by fatty inﬁltration.
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Introduction
The current obesity epidemic has increased the interest in
the development and function of adipose tissue, as well as
in mechanisms that could elevate whole-body energy expen-
diture. While white adipocytes store excess energy intake as
intracellular lipid droplets, brown adipocytes dissipate energy
as heat in response to cold exposure or a high-fat diet,
thereby decreasing metabolic efﬁciency. The ability of brown
adipocytes to dissipate energy as heat results from the
activity of uncoupling protein 1 (UCP1), which is located in
the inner mitochondrial membrane and uncouples the
electron transport chain from ATP production (extensively
reviewed in Cannon and Nedergaard1). In addition to classical
brown adipose tissue (BAT) depots, pockets of UCP1-positive,
multilocular adipocytes have also been described within
white adipose tissue (WAT) from rodents following cold
exposure,2–4 treatment with a beta 3-adrenergic agonist,5
or exercise training.6 These adipocytes are commonly
referred to as beige, brite (from brown in white), inducible,
or recruitable, reviewed in Chechi et al.7 and seem to result
from the transdifferentiation of previously unilocular, white
adipocytes4,5 and from the de novo differentiation of
precursor cells.8 It has been proposed that beige adipocytes
can derive from a distinct precursor and display a gene
expression pattern different from that of brown adipocytes.9
Recent studies also reported the presence of BAT and the
formation of UCP1-expressing adipocytes within WAT depots
in adult humans.10,11 In humans, UCP1-positive adipocytes
exhibiting both brown12–14 and beige13–16 molecular signa-
tures have been described.
In consequence, strategies to increase the amount or the
activation of these adipocytes have been investigated as ways
to prevent or counteract obesity and its associated disorders.
In fact, BAT amount and activity are negatively correlated
with body mass index and body fat percentage in adult
humans.11 In rodents, ectopic BAT interspersed between
skeletal muscle groups in the thigh and popliteal regions of
Sv129 mice protects against high-fat-diet-induced obesity as
compared with C57Bl/6J (C57Bl/6) mice, in which expression
of UCP1 is not detected in the same area.17 The origin of ec-
topic BAT, however, is currently much less understood than
the formation of classical BAT.
In addition to classical white and BAT depots, adipose
tissue can also accumulate in ectopic locations, including
skeletal muscle. Intramuscular adipose tissue—here deﬁned
as clusters of adipocytes interspersed between skeletal
muscle ﬁbres—is generally associated with systemic insulin
resistance,18,19 decreased muscle strength20 and, in older
adults, impaired mobility.21–23 In vitro, skeletal myotubes
treated with conditioned media from intramuscular
progenitor-derived adipocytes display decreased glucose
uptake and glycogen synthesis in response to insulin.24
Because brown adipocytes function as a sink for excess
glucose in the circulation, we hypothesize that shifting
intramuscular adipocytes towards a brown phenotype could
attenuate the negative impact of these cells on the surround-
ing myoﬁbers. Furthermore, given that skeletal muscle
accounts for more than 30% of body mass in humans,25
increases in energy uncoupling within this tissue could have
an important impact on whole-body energy expenditure.
The origin of ectopic UCP1-expressing adipocytes in skele-
tal muscle is still under debate. Seale et al.26 have shown that
primary myoblasts isolated from newborn mice are able to
differentiate into brown adipocytes when expression of the
transcription factor PRDM16 is induced. Consistent with this,
another study reported the differentiation of small subpopu-
lations of Pax7+ satellite cells (less than 10%) into adipo-
cytes.27 Importantly, the protocols used in these studies rely
on the exclusive labelling of myogenic progenitors, but not
other cell lineages, by Pax7 and Myf5. However, it has
recently been described that Myf5+ progenitors in WAT
depots can give rise to white adipocytes,28 indicating that
the spectrum of cell lineages is broader than previously
appreciated. In addition, there is evidence that skeletal
muscle mesenchymal cells distinct from myogenic progeni-
tors (MPs) differentiate into adipocytes. A lineage tracing
study reported that most adipocytes in skeletal muscle
derive from a Pax3 lineage and that adipocytes formed in
aged mice during muscle regeneration derive from Myf5
cells.29 Moreover, it has been shown that Sca1+/PDGFRα+
ﬁbro/adipogenic progenitors (FAPs) from skeletal muscle,
but not alpha 7-integrin+ myogenic progenitors, are able to
differentiate into adipocytes.30,31 Interestingly, FAPs isolated
from skeletal muscle of adult 129S6/SvEvTac (Sv/129) mice
are able to differentiate into UCP1-expressing adipocytes
when pre-treated with bone morphogenetic protein 7
(BMP7) before differentiation in vitro.32 In vivo,
intramuscular adipocytes have been characterized as white
in B6D2 mice,33 but it is unclear whether Ucp1 expression is
induced during muscle regeneration and intramuscular fat
formation in other mouse strains, particularly in Sv/129 mice,
which are known to express higher levels of Ucp1 in WAT
compared with other mouse strains.17
Here, we show induction of Ucp1 expression in skeletal
muscle during fatty inﬁltration in the obesity-resistant
mouse strain Sv129. Using monoclonal and polyclonal cell
cultures of skeletal muscle MPs and FAPs under different
media conditions, we identiﬁed FAPs as the stem cell
population able to form brown-like adipocytes. Uncoupling
protein 1 expression in differentiated FAPs depends on the
genetic background, sex, and thyroid hormone. The identiﬁ-
cation of brown-like adipocyte precursors and of the factors
driving their differentiation towards a brown adipogenic
phenotype could contribute to the development of new
strategies to treat obesity, insulin resistance, and associated
disorders, such as sarcopenia and skeletal muscle fatty
inﬁltration.
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Materials and methods
Animals
All mice were maintained in a 12 h light/dark cycle in a
pathogen-free animal facility. C57Bl6/6J and Sv/129 mice
were purchased from Harlan Laboratories (Horst, The Nether-
lands) and Taconic (Rensselaer, NY, USA), respectively.
Interleukin-6 knockout mice (B6.129S2-IL-6tm1Kopf/J) and
C57Bl/6 controls were purchased from Jackson Laboratory
(Bar Harbor, ME, USA). To induce the proliferation and differ-
entiation of FAPs in vivo, mice were anaesthetized with
isoﬂurane (Forane, Abbott, Wiesbaden, Germany), and one of
the tibialis anterior (TA) muscles was injected with cardiotoxin
(CTX, Sigma, Buchs, Switzerland, , 50 μL, 10 mM in phosphate
buffered saline) or glycerol [GLY, Sigma, 50 μL, 50% v/v in
Hank’s balanced salt solution (HBSS)]. Injections of HBSS into
TA muscles were previously shown to not elicit skeletal muscle
regeneration or intramuscular adipocyte deposition33; there-
fore, we used the uninjected contralateral muscles as control
as described before.30,31,34 To promote Ucp1 expression in
GLY-induced intramuscular adipocytes, mice received intraper-
itoneal injections of CL316,243 hydrate (CL316, 0.5 mg/kg
body mass in saline) for ﬁve consecutive days 4 weeks after in-
tramuscular injection of GLY. To access the effect of cold expo-
sure on Ucp1 expression in uninjected skeletal muscle, mice
were kept for 1 week at 8°C as previously described.4 All ani-
mal studies were approved by the Ethics Committee of the
Cantonal Veterinary Ofﬁce Zürich, and the principles of
laboratory animal care were followed.
Skeletal muscle histology
For histological analysis, skeletal muscle was dissected and ﬂash
frozen in isopentane cooled in liquid nitrogen. Frozen cross sec-
tions of 30 μm were prepared from different areas of the TA
muscle and stained with haematoxylin and eosin. Representa-
tive images were obtained with a digital camera (Zeiss AxioCam
HRc) connected with a microscope (Zeiss Axioplan2).
Skeletal muscle primary cell cultures
For the isolation of primary skeletal muscle cells, murine
skeletal muscle tissue was excised from the hind limbs (and
when indicated also from the paraspinal muscle) and
processed as previously described.35 In brief, muscle tissue
was digested with 2 mg/mL collagenase type II (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) in collagenase buffer [2% bovine
serum albumin (Sigma) in HBSS] for 1 h (3 × 20 min) at 37°C,
followed by erythrocyte lysis (erythrocyte lysis buffer: 154 mM
NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA) and ﬁltration using
40 μM cell strainers. After incubation with ﬂuorescent
antibodies, pure populations of MPs and FAPs cells, respectively,
were obtained using ﬂuorescence-activated cell sorting (FACS,
BD FACSAria III, BD Biosciences, San Diego, CA, USA).
Fibro/adipogenic progenitors were sorted based on positive
staining for Sca1 and absence of staining for alpha 7-integrin,
CD31, and CD45,30 while MPs were sorted based on positive
staining for alpha 7-integrin and absence of Sca1, CD31, and
CD45.35 For analysis of monoclonal cell colonies, single FAPs
and MPs were sorted directly into 96-well cell culture plates
containing growth medium. Allophycocyanin (APC)-conjugated
anti-mouse Ly-6A/E (Sca-1), Alexa Fluor® 488-conjugated anti-
mouse CD31, and Alexa Fluor® 488-conjugated anti-mouse
CD45 antibodies were purchased from BioLegend (London,
UK); PE-conjugated anti-mouse alpha 7-integrin antibody was
purchased from R&D Systems (Minneapolis, MN, USA).
Fibro/adipogenic progenitors were grown in low-glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Invitrogen, Carls-
bad, CA, USA) containing 20% foetal bovine serum (FBS,
Invitrogen), 1% penicillin/streptomycin (P/S, Invitrogen), and
5 ng/mL basic ﬁbroblast growth factor (Invitrogen). Myogenic
progenitors were grown on collagen-coated plates in culture
medium containing 40% F10 nutrient mixture, 40% low-glucose
DMEM, 20% FBS, 1% P/S, and 5 ng/mL basic ﬁbroblast growth
factor. Myogenic differentiation medium contained 2% horse
serum (Invitrogen) and 1% P/S in low glucose DMEM. To stim-
ulate adipogenic differentiation, cells were treated for 2 days
with high-glucose DMEM supplemented with 10% FBS, 1%
P/S, 5 μg/mL insulin, 125 μM indomethacin, 5 μM dexametha-
sone, 0.5 mM isobutylmethylxanthine, 1 nM triiodothyronine
(T3), and 1 μM rosiglitazone (brown adipogenic induction me-
dium); subsequently, cells were kept in high-glucose DMEM
containing 10% FBS, 1% P/S, 5 μg/mL insulin, 1 nM T3, and
1 μM rosiglitazone (brown adipogenic differentiation medium)
for up to 8 days. Where indicated, T3 was not added to the
brown adipogenic induction and differentiation media. All cells
were cultured in a 5% CO2 atmosphere at 37°C.
White adipose tissue primary cultures
For isolation of primary cells from WAT, inguinal WAT
(ingWAT) was excised and digested with 2 mg/mL collagenase
in collagenase buffer (25 mM NaHCO3, 12 mM KH2PO4,
1.2 mM MgSO4·7H2O, 4.8 mM KCl, 120 mM NaCl, 1.4 mM
CaCl2·2H2O, 5 mM glucose, 2.5% bovine serum albumin,
and 1% P/S) for 1 h at 37°C; after centrifugation, the resulting
pellet containing the stromal vascular fraction was washed,
erythrocytes were lyzed using erythrocyte lysis buffer, and
cells were ﬁltered through 40 μm and plated in collagen-
coated cell culture plates containing growth medium (10%
FBS and 1% P/S in high-glucose DMEM). Two days after
reaching conﬂuence, cells were differentiated with the
same brown adipogenic media used for skeletal muscle MPs
and FAPs.
UCP1 expression in skeletal muscle FAPs 3
Journal of Cachexia, Sarcopenia and Muscle 2018
DOI: 10.1002/jcsm.12277
RNA isolation and quantitative reverse
transcription PCR
Total RNA was isolated using the TRIzol reagent (Invitrogen).
After DNAse digestion of total RNA (DNA-free DNA Removal
kit, Ambion, Thermo Fisher Scientiﬁc, Waltham, MA, USA),
complementary DNA was synthesized with random hexamer
primers using Super Script III Reverse Transcriptase (Super-
Script® III First-Strand Synthesis System, Invitrogen). mRNA
was analysed by quantitative reverse transcription PCR with
a 7500 Fast Start Real-Time PCR system (Applied Biosystems
Foster City, CA, USA) using the FastStart Universal SYBR Green
Master Mix (Roche, Basel, Switzerland). Transcript levels
were normalized to 18S ribosomal RNA levels. Primer se-
quences are available upon request.
Protein extraction and western blotting
Cells and tissues were lyzed in radioimmunoprecipitation as-
say buffer. For western blotting, cell lysates were separated
by sodium dodecyl sulphate–polyacrylamide gel electropho-
resis and transferred onto polyvinylidene ﬂuoride mem-
branes. Proteins were detected using the following
antibodies: UCP1 (Merck Millipore, Darmstadt, Germany,
662045, 1:1000 dilution), fatty acid-binding protein 4
(FABP4, Cell Signaling, Beverly, MA, USA, 3544, 1:1000 dilu-
tion), myosin heavy chain (MyHC) (Developmental Studies
Hybridoma Bank, MF 20, 1:100 dilution), beta-actin (ACTB,
Proteintech, Manchester, UK, 20536-1-AP, 1:2000 dilution),
mouse immunoglobulin (IgG) (Merck Millipore, 401253,
1:8000 dilution), and rabbit IgG (Merck Millipore, 401393,
1:8000 dilution).
Immunoﬂuorescence and image analysis
Fibro/adipogenic progenitors were grown and differentiated
on chamber slides (Sigma). At Day 10 of differentiation, cells
were ﬁxed, permeabilized, and incubated overnight with rab-
bit anti-UCP1 (Abcam, Cambridge, UK, 1:500 dilution),
followed by incubation with Alexa 488 anti-rabbit IgG and
DAPI. Slides were posteriorly analysed with a confocal laser
scanning microscope (SP5 Resonant APD, Leica, Wetzlar,
Germany).
For quantiﬁcation of differentiated and UCP1+ cells, FAPs
were seeded and differentiated into a 96-well plate and poste-
riorly ﬁxed and stained with LD540 (lipid droplets), Hoechst
(nuclei), and rabbit anti-UCP1 (Abcam, 1:500 dilution) followed
by incubation with Alexa 488 anti-rabbit IgG; 17 pictures were
taken per well using an automated microscope imaging
system (PerkinElmer Operetta High Content Imaging System,
Perkin Elmer, Waltham, MA, USA).
Immunohistochemistry
IngWAT and TA muscles were excised, ﬁxed in 4% formalin,
and embedded in parafﬁn using a benchtop tissue processor
(TP1020, Leica Biosystems). Sections of 4 μm thickness were
prepared using a microtome (RM2255, Leica Biosystems)
and deparafﬁnized. For immunostaining, endogenous peroxi-
dase activity was blocked by incubation in 3% H2O2, followed
by heat-induced epitope retrieval in 0.01 M sodium citrate.
Tissue sections were then incubated with primary antibodies
against UCP1 (Thermo Fisher Waltham, MA, USA, PA1-24894,
1:200) or cytochrome c oxidase subunit IV (Abcam, ab16056,
1:250), and signals were visualized using SignalStain® Boost
IHC Detection Reagent (Cell Signaling, 8114) and the
SignalStain® DAB Substrate kit (Cell Signaling, 8059).
Statistical analyses
Student’s t-tests were used for pairwise comparisons and
one-way or two-way analyses of variance with Bonferroni
post hoc tests were used for comparisons between more than
two groups. A signiﬁcance level of 0.05 was considered for all
tests. Results are shown as means ± standard error of the
mean. All statistical analyses were performed using GraphPad
Prism. When gene expression values did not show a normal
distribution, data were log transformed before statistical
analysis. For experiments in which at least one sample had
an undetermined Ct value for a given gene, half of the lowest
detectable value was added to all samples, allowing for
logarithmic transformation.
Results
Intramuscular adipogenesis induces uncoupling
protein 1 expression in skeletal muscle of
obesity-resistant mice
Intramuscular adipocyte formation in mice is rare compared with
humans but can be stimulated by intramuscular injection of either
GLY or CTX.33,34 To determine whether adipocyte formation can
induce Ucp1 expression in skeletal muscle, we injected GLY or
CTX into the TA muscle of mice, a skeletal muscle that contains
no signiﬁcant amounts of adipocytes under basal conditions (Fig-
ure 1A). We used Sv/129 mice, which express detectable Ucp1
levels in subcutaneous WAT even under non-stimulated condi-
tions.17 In line with a previous report,34 adipocyte formation
was observed in the TA muscles 4 weeks after the intramuscular
injections but was more pronounced following GLY injection (Fig-
ure 1A). Accordingly, we observed that the mRNA levels of the
general adipocyte markers Pparg2 and Fabp4 were signiﬁcantly
increased in both regeneration models (Figure 1B). Importantly,
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Figure 1 Glycerol (GLY), but not cardiotoxin (CTX), induces intramuscular adipogenesis and uncoupling protein 1 (Ucp1) expression in skeletal muscle,
which responds to treatment with a beta 3-adrenergic agonist. (A) Haematoxylin and eosin staining of tibialis anterior (TA) cross sections 4 weeks after
intramuscular injection of CTX or GLY. (B) mRNA levels of general (Pparg2 and Fabp4) and brown (Ucp1 and Cidea) adipocyte markers in TA 4 weeks
after intramuscular GLY injection in 129S6/SvEvTac (Sv/129) male and Sv/129 female mice and 4 weeks after intramuscular CTX injection in Sv/129
female mice, n = 5 mice at 15 weeks of age per group. *P< 0.05, **P< 0.01, ***P< 0.001, and ****P< 0.0001, repeated measures two-way analysis
of variance. (C) Ucp1 mRNA levels in TA muscles of uninjected Sv/129 male mice kept at room temperature or exposed to cold (8°C) for 1 week. n = 5,
unpaired Student’s t-test. (D, E) Four weeks after intramuscular GLY injection in the TA muscles, mice were treated with daily injections of CL316,243
hydrate (CL316) for 5 days, and TA muscles were excised for quantiﬁcation of Ucp1, Cidea, and Pparg2 mRNA levels and immunohistochemical analysis
of parafﬁn sections; inguinal white adipose tissue (ingWAT) was used as a control. n = 5 Sv/129 female mice at 17 weeks of age per group. *P < 0.05
and ***P < 0.001, unpaired Student’s t-test. For (B–D), mRNA levels were measured by quantitative reverse transcription PCR. Results are shown as
mean and standard error of the mean of mRNA levels normalized to 18S rRNA levels, in arbitrary units (A.U.). In (E), ‘*’ indicates a corresponding area
on consecutive sections, and arrows indicate UCP1+/cytochrome c oxidase subunit IV (COX IV)+ adipocytes. Scale bar = 100 μm. CL316, CL316,243
hydrate.
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mRNA levels of the brown adipocyte markers Ucp1 and Cidea,
barely detectable in the non-injected control legs, were mark-
edly elevated in response to the GLY injections (Figure 1B). No
signiﬁcant differences in the response to GLY injections were
observed between male and female mice (Figure 1B). Con-
trasting with the increase in intramuscular Ucp1 expression
following GLY injection, Ucp1 levels in TA muscles of
uninjected mice remained low even after cold exposure for
1 week (Figure 1C). These results point to newly formed intra-
muscular adipocytes as the source of Ucp1 expression in skel-
etal muscle.
Uncoupling protein 1 up-regulation in response to cold
exposure via the stimulation of beta 3-adrenergic receptors
is a remarkable feature of brown36 and beige3 adipocytes.
Ectopic Ucp1 expression in ingWAT, for example, increases al-
most ﬁve-fold following treatment with the beta 3-adrenergic
agonist CL316.17 To test the response of intramuscular Ucp1
levels to beta 3-adrenergic stimulation in vivo, Sv/129 female
mice were treated with CL316 for ﬁve consecutive days
4 weeks after intramuscular injection of GLY into the TA
muscles. Notably, intramuscular mRNA levels of Ucp1 and
Cidea were markedly elevated in CL316-treated compared
with control mice, similarly to ingWAT, and independent
from adipocyte differentiation levels as measured by Pparg2
expression (Figure 1D). Histological analysis of CL316-
stimulated GLY-injected TA muscles revealed pockets of
intramuscular adipocytes expressing both UCP1 protein and
the mitochondrial marker cytochrome c oxidase subunit IV,
similarly to ingWAT (Figure 1E). Together, we conclude that
UCP1 expression in intramuscular adipocytes can be regu-
lated through a classical brown adipocyte pathway.
Fibro/adipogenic progenitors, but not myogenic
progenitors, differentiate into uncoupling protein
1-expressing adipocytes
Our next aim was to determine the potential source for
UCP1-expressing intramuscular adipocytes. At least two stem
cell populations have been proposed as the precursors for in-
tramuscular Ucp1-expressing adipocytes: satellite cells/MPs27
and FAPs.32 To deﬁne the potential of MPs and FAPs to differ-
entiate into UCP1+ adipocytes, we used FACS to isolate both
populations from skeletal muscle based on expression of
the surface markers alpha 7-integrin and Sca1, respectively.
First, we addressed the potential of MPs to form adipocytes
and expanded them as myoblasts under cell culture condi-
tions. Nearly conﬂuent myoblasts were treated with myogenic
or brown adipogenic medium for 8 days. As expected, myo-
blasts treated with myogenic medium differentiated into
MyHC-expressing myotubes (Figure 2A). Remarkably, myo-
blasts were still able to form MyHC+ myotubes and did not dif-
ferentiate into adipocytes even when treated with brown
adipogenic medium (Figure 2A). In contrast, stromal vascular
fraction cells isolated from ingWAT, used as a control, readily
differentiated into FABP4+ adipocytes upon treatment with
the same medium (Figure 2A). Adipocyte formation was also
not observed when myoblasts from Sv/129 or C57Bl/6 mice
were treated with brown adipogenic medium further supple-
mented with different compounds reported to promote brown
adipogenic differentiation (Figure 2B). Because polyclonal cell
culture conditions could be disadvantageous for adipogenic
subclones, we next sorted single MPs directly into 96-well
plates and, after expansion, treated the monoclonal colonies
for 10 days with brown adipogenic medium. Similarly to our
initial results, adipogenesis was again not observed and
myotube formation occurred to different extents, conﬁrming
the commitment of MPs to the myogenic fate (Figure 3). Im-
portantly, more than 30% of monoclonal colonies derived from
single-sorted FAPs contained adipocytes following the same
treatment (Figure 3). These results demonstrate that the lack
of adipocyte formation in monoclonal colonies of MPs cannot
simply be explained by the cell culture conditions (Figure 3).
Together, these data suggest that MPs are strictly committed
to the myogenic lineage and do not have the potential to dif-
ferentiate into adipocytes even under adipogenic conditions.
In contrast to MPs, FAPs readily differentiated into
multilocular adipocytes (Figure 4C) expressing UCP1 and
FABP4 in response to the brown adipogenic treatment
(Figure 4A). In addition to Ucp1, other genes, which are
highly expressed in brown adipocytes, were also signiﬁcantly
up-regulated in differentiated FAPs, including Pgc1a, Cidea,
Prdm16, Elovl3, and Eva1 (Figure 4B). Therefore, our results
show that FAPs, but not MPs, are the likely source for
UCP1-expressing intramuscular adipocytes.
Uncoupling protein 1 levels in ﬁbro/adipogenic
progenitor-derived adipocytes depend on mouse strain
Previous studies have shown that adipocyte precursors
residing in WAT and skeletal muscle from C57Bl/6 and
Sv/129 mice differ in their potential to express UCP1
following differentiation.32,37 In line with these ﬁndings, we
observed higher levels of UCP1 in skeletal muscle FAPs iso-
lated from Sv/129 mice than in those isolated from C57Bl/6
mice after the brown adipogenic treatment (Figure 4A). This
conﬁrms that FAPs isolated from skeletal muscle of different
mouse strains retain genetic differences, which affect UCP1
expression under cell culture conditions.
Uncoupling protein 1 expression in
ﬁbro/adipogenic progenitor-derived adipocytes
responds to the thyroid hormone triiodothyronine
The thyroid hormone T3 plays an important role in the activa-
tion of brown adipocytes, and thyroidectomized rats exhibit
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impaired BAT activation and thermoregulation in response to
cold.38,39 In vitro, it has been shown that T3 up-regulates
UCP1 expression in foetal rat brown adipocytes40 and human
multipotent adipose-derived stem cells under adipogenic
conditions.41 Similarly, we observed higher UCP1 expression
levels in FAPs differentiated with medium supplemented with
T3 (+T3) compared with cells differentiated with medium lack-
ing addition of T3 (T3). The expression of the adipocyte
marker FABP4 was not decreased in cells treated with
medium –T3 (Figure 4A), indicating that the increased UCP1
expression was not a mere consequence of enhanced differ-
entiation. Uncoupling protein 1 was also up-regulated in
response to T3 at the mRNA level together with the inducer
of mitochondrial biogenesis Pgc1a (Figure 4B). Up-regulation
of the transcriptional co-regulator of Pgc1a, Prdm16, during
differentiation also depended on addition of T3 to the
medium, while other brown adipocyte markers remained
unchanged (Eva1 and Cidea) or showed a slightly lower
expression (Elovl3) (Figure 4B). mRNA levels of the general
adipocyte markers Pparg2 and Fabp4 did not differ between
cells differentiated with medium +T3 and T3, conﬁrming
that T3 supplementation does not enhance adipocyte differ-
entiation (Figure 4B). To further deﬁne the mechanisms for
the T3-dependent increase in UCP1 expression, differentiated
FAPs were stained for lipid droplets (LD540 dye), nuclei
(DAPI), and immunostained for UCP1; UCP1+ cells and differ-
entiated adipocytes were then quantiﬁed using an auto-
mated microscope imaging system. We observed a slight
increase in the percentage of UCP1+ adipocytes in cultures
differentiated in medium +T3 compared with cells differenti-
ated with medium T3 (Figure 4D), while the percentage of
differentiated cells was similar in both conditions. This
supports the notion that the increased UCP1 expression in
response to T3 is independent of cell differentiation and
reﬂects both an increase in the number of cells expressing
UCP1 and higher UCP1 levels per cell.
Uncoupling protein 1 expression in
ﬁbro/adipogenic progenitor-derived adipocytes is
sex dependent
Ucp1 expression in adipocytes can be sex dependent as
previously shown for rat BAT42 and in differentiated stem
cells from human perirenal adipose tissue.43 We also
observed a tendency for higher Ucp1 expression levels in
Figure 2 Myoblasts are committed to the myogenic fate under treatment with brown adipogenic medium. (A) Expression of the adipocyte marker
fatty acid-binding protein 4 (FABP4), different isoforms of the myotube marker myosin heavy chain (MyHC), and glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) (loading control) in primary mouse myoblasts following 8 days of differentiation in myogenic or brown adipogenic medium (n = 2
cultures from individual 129S6/SvEvTac (Sv/129) male mice per condition). Cells from the stromal vascular fraction of inguinal white adipose tissue
(WAT SVF) differentiated for 8 days with adipogenic medium were used as a control [n = 1 culture from a C57Bl6/6J (C57Bl/6) female mouse and 1
culture from a C57Bl/6 male mouse]. Brown adipose tissue (BAT) was used as a positive control. (B) Representative light microscopy images of myo-
blasts isolated from C57Bl/6 and Sv/129 mice following 10 days of differentiation in brown adipogenic medium supplemented with the indicated com-
pounds (BMP7, FGF21, ANP, and ActRIIB), ×50 magniﬁcation. ActRIIB, activin receptor IIB inhibitor; ANP, atrial natriuretic peptide; BMP7, bone
morphogenetic protein 7; FGF21, ﬁbroblast growth factor 21.
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GLY-injected TA muscles from female compared with male
Sv/129 mice in vivo (Figure 1B). Therefore, we compared
the potential of skeletal muscle FAPs from male and female
mice to express UCP1 following brown adipogenic differenti-
ation in vitro. Interestingly, FAPs isolated from Sv/129
female mice reached higher UCP1 levels after differentiation
compared with FAPs isolated from Sv/129 male mice
(Figure 5A and 5B). The expression levels of the adipocyte
marker FABP4 were not different between groups, indicating
that the differences in UCP1 levels were not dependent on
differentiation. (Figure 5B). The difference in UCP1 expres-
sion after differentiation between FAPs isolated from male
and female mice was also observed in C57Bl/6 mice (data
not shown).
Together, our results demonstrate that FAPs isolated from
skeletal muscle of not only different mouse strains but also
different sexes retain genetic differences, which inﬂuence
UCP1 expression following differentiation.
Intramuscular uncoupling protein 1 expression
after glycerol-induced fatty inﬁltration is preserved
in interleukin-6 knockout and aged mice
Fibro/adipogenic progenitor fate is strongly determined by
the surrounding muscle environment.30,31 Inﬁltration by
neutrophils, macrophages, and eosinophils and inﬂamma-
tion are hallmarks of muscle regeneration.34,44 Moreover,
FAPs have been shown to be an inducible source of IL-6, in-
creasing IL-6 expression for at least 5 days following muscle
damage.30 To understand the role of IL-6 in Ucp1 expression
upon experimental fatty inﬁltration, we examined IL-6
knockout mice 4 weeks following intramuscular GLY injec-
tions (followed or not by CL316 treatment). Intriguingly, nei-
ther adipocyte deposition as determined by the expression
levels of Pparg2 nor GLY-induced Ucp1 expression was al-
tered in the mutant mice (Figure 6). These results demon-
strate that IL-6 is dispensable for intramuscular fatty
Figure 3 Monoclonal cultures of ﬁbro/adipogenic progenitors (FAPs), but not myoblasts, have the potential to differentiate into adipocytes. FAPs and
myoblasts were isolated from skeletal muscle (hindlimbs and paraspinal), and single cells were ﬂuorescence-activated cell sorting sorted directly into
96-well plates. Nearly conﬂuent cells were treated for 10 days with brown adipogenic medium. Adipocyte formation was assessed through microscopy
in 315 FAP and 88 myoblast monoclonal cultures from C57Bl6/6J (C57Bl/6) (46 myoblast and 143 FAP colonies) and 129S6/SvEvTac (42 myoblast and
172 FAP colonies) male mice. Shown are representative light microscopy images of monoclonal colonies of FAPs (×100 magniﬁcation) and myoblasts
(×50 magniﬁcation).
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Figure 4 Fibro/adipogenic progenitors (FAPs) differentiate into brown-like adipocytes in a strain-dependent and T3-dependent manner. FAPs were iso-
lated from skeletal muscle (hindlimbs) of 129S6/SvEvTac (Sv/129) and C57Bl6 mice and, upon conﬂuence, differentiated for 10 days with brown
adipogenic medium supplemented (+T3) or not (T3) with triiodothyronine. (A) Uncoupling protein 1 (UCP1), fatty acid-binding protein 4 (FABP4),
and beta-actin (ACTB) (loading control) protein expression in differentiated FAPs. Results are shown as mean and standard error of the mean
(SEM) of relative protein expression levels normalized to ACTB relative levels in arbitrary units (A.U.), n = 6 mice; *P < 0.05, **P < 0.01, and
****P < 0.0001, repeated measures two-way analysis of variance. (B) mRNA levels of general and brown adipocyte markers in FAPs at Day 0 and
at Day 10 of differentiation in medium +T3 or medium T3. Results are shown as mean ±SEM of gene expression levels normalized to 18S rRNA levels,
in A.U., n = 6 Sv/129 female mice; a: signiﬁcantly different from undifferentiated cells and b: signiﬁcantly different from cells differentiated with me-
dium T3, repeated measures one-way analysis of variance. (C) Representative light microscopy images (×100 magniﬁcation) of FAPs at Day 0 and at
Day 10 of differentiation with medium +T3 or T3. (D) FAPs at Day 10 of differentiation (+T3 or T3) were stained for nuclei (DAPI) and lipid droplets
(LD540) and immunostained for UCP1. Automated image acquisition was followed by automated quantiﬁcation of cells positive for UCP1 and of dif-
ferentiated cells (i.e. cells containing lipid droplets). Results are shown as mean and SEM of percentage of cells positive for UCP1 or percentage of
differentiated cells; n = 10 Sv129 female mice, **P < 0.01, paired Student’s t-test.
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inﬁltration and Ucp1 expression, at least in this animal
model.
It is tempting to speculate that browning of intramuscular
adipocytes could improve skeletal muscle function in condi-
tions such as ageing/sarcopenia, in which skeletal muscle fatty
inﬁltration is associated with poor outcomes.22 However,
whether the ability of FAPs to differentiate into Ucp1-
expressing adipocytes is preserved in older/sarcopenic
individuals remains unclear. Thus, we assessed the presence
of Ucp1 expression in an experimental condition of
sarcopenia. To this end, 18 months old Sv/129 female mice
received intramuscular injections of GLY into the TA and were
compared with younger mice (3 months old). While TA muscle
weight was not signiﬁcantly affected by age (data not shown),
aged muscle expressed higher levels of the two muscle-
speciﬁc E3 ubiquitin ligases muscle RING ﬁnger 1 and muscle
Figure 5 Sex-dependent uncoupling protein 1 (UCP1) expression in differentiated ﬁbro/adipogenic progenitors (FAPs). (A) FAPs isolated from skeletal
muscle (hindlimbs) of male and female 129S6/SvEvTac (Sv/129) mice were differentiated for 10 days, stained for nuclei (DAPI), and immunostained for
UCP1, n = 3 mice per group. Scale bar = 50 μM. (B) UCP1, fatty acid-binding protein 4 (FABP4), and beta-actin (ACTB) (loading control) protein expres-
sion in FAPs isolated from Sv/129 male and female mice at Day 10 of differentiation. Results are shown as mean and standard error of the mean of
relative protein expression levels normalized to ACTB relative levels in arbitrary units (A.U.), n= 5 mice per group. *P < 0.05, unpaired Student’s t-test.
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atrophy F-box (Atrogin-1), which are reportedly increased
during muscle atrophy at the transcriptional level45 (Figure 7).
Importantly, intramuscular GLY injections induced an
up-regulation of Pparg2 and Ucp1 mRNA levels to the same
extent in TA muscles of young and aged mice (Figure 7). This
suggests that even in aged skeletal muscle, in which a
Figure 6 Intramuscular uncoupling protein 1 (Ucp1) expression after glycerol-induced fatty inﬁltration does not depend on interleukin 6 (IL-6). Tibialis
anterior muscles from 12 weeks old female IL-6 knockout (KO) or wild-type C57Bl6/6J control mice were injected with glycerol. The uninjected con-
tralateral muscles served as control. After 4 weeks, mice were treated with ﬁve daily intraperitoneal injections of CL316,243 (+CL316) or saline
(CL316). Pparg2 and Ucp1 mRNA levels were determined using quantitative reverse transcription PCR and normalized to 18S rRNA, n = 5 mice
per group. Data are shown as mean and standard error of the mean. *P < 0.05, **P < 0.01, and ****P < 0.0001 for group effect of glycerol injection,
two-way analysis of variance and Bonferroni post hoc test.
Figure 7 Ageing does not affect intramuscular uncoupling protein 1 (Ucp1) expression after glycerol-induced fatty inﬁltration. Tibialis anterior muscles
from young (3 months) or aged (18 months) female 129S6/SvEvTac mice were injected with glycerol. The uninjected contralateral muscles served as
control. After 4 weeks, muscles were excised and atrogin-1, MuRF-1, Pparg2, and Ucp1 mRNA levels were determined using quantitative reverse tran-
scription PCR and normalized to 18S rRNA, n = 8 mice per group. Data are shown as mean and standard error of the mean. *P < 0.05 and **P < 0.01
for young vs. aged, ****P < 0.0001 for group effect of glycerol injection, two-way analysis of variance and Bonferroni post hoc test.
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molecular signature of sarcopenia is already present, the
ability of GLY-induced adipocytes to acquire a brown-like
phenotype is preserved.
Discussion
Our study provides a comprehensive analysis of UCP1
expression in skeletal muscle based on two in vivo models
of intramuscular adipogenesis and the prospective isolation
of two different skeletal muscle progenitor cell popula-
tions. We show that Ucp1 expression is increased in
skeletal muscle following GLY-induced intramuscular adipo-
genesis in an obesity-resistant mouse strain and that
intramuscular Ucp1 expression is responsive to beta
3-adrenergic stimulation. Furthermore, we observed that
skeletal muscle FAPs, but not MPs, are able to differenti-
ate into UCP1+ adipocytes ex vivo, with UCP1 levels being
affected by both genetic factors (background and sex) and
hormonal signalling (T3).
The intramuscular injections of either CTX or GLY are
widely established protocols to induce muscle regeneration
and the formation of intramuscular adipocytes.29,30,33,34
Both models involve the proliferation of satellite cells
and FAPs followed by satellite cell fusion to damaged
myoﬁbers and intramuscular adipogenesis. In line with
our results, intramuscular adipogenesis was reported to
be stronger and more persistent following intramuscular
GLY injections.34 Additionally, we show that these two
skeletal muscle regeneration models also differ regarding
the induction of brown adipocyte markers: signiﬁcant
increases in the mRNA levels of Ucp1 and Cidea were only
observed in response to GLY injections. Thus, intramuscular
GLY injection provides a suitable model to study intramus-
cular formation of adipocytes expressing Ucp1 in obesity-
resistant mice.
In humans, intramuscular adipose tissue is generally
associated with impaired myoﬁber function, both from a
mechanical20 and a metabolic point of view.18,19 Although
this adipose tissue depot is not yet fully characterized,
studies analysing CTX-induced and GLY-induced adipogene-
sis in murine skeletal muscle describe the intramuscular
adipocytes as white rather than brown.29,33,34 In contrast,
the increase in Ucp1 expression in skeletal muscle that we
observed during GLY-induced adipogenesis suggests that
intramuscular adipocyte precursors can also adopt a
brown-like phenotype in an obesity-resistant mouse strain.
The further increase in intramuscular Ucp1 and Cidea
expression in response to beta 3-adrenergic stimulation
resembles the browning process of WAT depots and points
to intramuscular adipocytes as a possible and accessible
target for therapies promoting the brown adipocyte-like
phenotype. It remains to be shown whether brown-like
intramuscular adipocytes could improve skeletal muscle
metabolism and insulin sensitivity in skeletal muscle
affected by fatty inﬁltration.
The identity of the skeletal muscle progenitor population
able to differentiate into brown-like adipocytes is currently
under debate. Previous studies claimed that MPs are able
to differentiate into white46–48 or brown-like adipocytes26,27
under certain conditions. However, most of these studies
relied on single muscle ﬁbre isolations46–48 or on pre-plating
of collagenase-digested tissue47 to obtain the progenitor
populations, which could potentially result in the isolation
of non-myogenic, interstitial cells surrounding myoﬁbers.
Indeed, Starkey et al.49 reported that most adipogenic clones
that derived from single myoﬁbers could be removed by
adding two myoﬁber washes to the isolation protocol before
plating the cells. Moreover, studies that observed adipogenic
differentiation of MPs identiﬁed the myogenic progenitors
by labelling for Pax7 or the myogenic regulatory factor
Myf5. However, recent studies showed that Myf5 can be
more widely distributed than previously appreciated and
also labels white adipocytes.28 Moreover, a subpopulation
of Myf5+ cells from extraocular muscle expresses Sca1 and
is adipogenic.50 In our study, we relied on a prospective
isolation strategy to obtain MPs from skeletal muscle by
FACS based on the absence of CD31, CD45, and Sca1 and
the presence of alpha 7-integrin, which results in highly pure
myogenic cultures.35 Analysing both polyclonal and monoclo-
nal cell cultures, we could not identify any MP subpopulation
with adipogenic potential. Our results further support
previous work showing that MPs are committed to the
myogenic fate30,31,49,51 and that FAPs are the adipocyte
precursor population residing in murine30–32,52 and
human24,51,53,54 adult skeletal muscle. Although we cannot
reject the hypothesis that a small subpopulation of satellite
cells could form brown adipocytes—as shown by Yin
et al.27 relying on the expression of Pax7 exclusively in
muscle satellite cells—our results suggest that FAPs are a
more likely source for intramuscular adipocytes and bear
the necessary machinery to express UCP1.
Notably, we show that FAPs differentiate into brown-like
adipocytes more readily than previously appreciated, that is,
without any pre-differentiation exposure to adipocyte
browning agents such as BMP7.55 The differences in UCP1
expression following FAP differentiation between previous
studies and ours could be explained at least partially by
differences in cell culture conditions. Firstly, Ucp1 expres-
sion in response to BMP7 in FAPs differentiated in the
absence of a PPARg agonist has been reported to be highly
dependent on the serum batch used.55 This could explain
the low Ucp1 expression in protocols that do not include
the PPARg agonist rosiglitazone in the differentiation
medium.29,31,32 Moreover, we show that the thyroid
hormone T3 is critical for UCP1 expression in differentiated
FAPs, and this hormone was not always included in the
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differentiation medium.30,31 Lastly, studies using cells
that have been passaged or frozen thawed prior to
differentiation report low Ucp1 levels in FAP-derived
adipocytes.24 Similarly, a decrease in differentiation and
UCP1 expression following cell passaging has been previ-
ously reported for CD34+ cells isolated from human foetal
skeletal muscle.56 We have also noticed a decrease in the
proliferation and differentiation capacity of FAPs after
trypsinization and re-seeding and therefore used only
freshly isolated cells expanded for a maximum of 10 days
in our experiments.
The up-regulation of UCP1 mRNA and protein levels in
response to T3 treatment in differentiated FAPs underscores
the importance of T3 for UCP1 expression in adipocytes,
already observed in studies with rat BAT cells40 and human
multipotent adipose-derived stem cells.41 Importantly, in
our study, this effect was dependent on a direct effect of T3
on UCP1 levels rather than on FAP differentiation, as indi-
cated by similar mRNA and protein levels of adipocyte
markers and automated microscopy analysis of differentia-
tion. We speculate that the increase in UCP1 gene and
protein expression in FAPs differentiated in medium
supplemented with T3 could result at least partially from
the stimulation of thyroid hormone response elements in
the Ucp1 gene promoter,57 increased stability of Ucp1
mRNA,40 and/or enhanced mitochondriogenesis (extensively
reviewed in Wrutniak-Cabello et al.58). In addition to intra-
muscular adipocytes being a target for T3-induced thermo-
genesis, our results also point to FAPs as a possible tool to
further dissect the effects of T3 on thermogenesis and UCP1
expression.
We observed two genetic factors affecting UCP1 levels
in differentiated FAPs: background and sex. The differences
in UCP1 expression after differentiation between FAPs
isolated from C57Bl/6 and Sv/129 mice are in line with
previous results obtained in adipogenic progenitors
isolated from skeletal muscle,32 subcutaneous WAT, and
epididymal WAT32,37 of these strains and highlight the
importance of genetic background on the ectopic expres-
sion of UCP1.17,59,60 Regarding differences in brown and
brown-like adipocytes between sexes, evidence is scarcer
and mostly derives from human studies. For example, pre-
vious studies have reported that functionally active BAT11
and UCP1+ adipocytes in perirenal adipose tissue43 are
more frequently found in women than in men. Addition-
ally, perirenal mesenchymal stem cells isolated from
women express higher mRNA (but not protein) levels of
Ucp1 after differentiation than those isolated from
men.43 Further analysis of the differences between FAPs
isolated from male and female mice or from mice of dif-
ferent genetic backgrounds could identify factors leading
to enhanced UCP1 expression in intramuscular adipose
tissue and potentially also in WAT depots. Finally, our
observation that genetic differences affect the potential
of skeletal muscle FAPs to express UCP1 following differentia-
tion could have implications for the development of interven-
tions to promote a brown phenotype in intramuscular
adipocytes in speciﬁc populations.
Whether our results are also applicable for humans is
currently not clear. Previous studies have shown
adipogenic potential for CD56/CD15+,24,61 CD56/
PDGFRα+,54 or CD56/CD15+/PDGFRα+51 progenitors iso-
lated from human skeletal muscle. These progenitors have
been described to give rise to bona ﬁde white adipocytes
that are insensitive to insulin-induced glucose uptake com-
pared with adipocytes derived from progenitors isolated
from subcutanous adipose tissue.51 In contrast, Uezumi
et al.54 showed that skeletal muscle PDGFRα+ progenitor-
derived adipocytes from humans express both white
(Leptin) and brown (UCP1) adipocyte-speciﬁc genes. Future
experiments should clarify whether human intramuscular
adipocytes have the potential to differentiate into brown-
like adipocytes.
Interleukin-6 expression is required for macrophage inﬁl-
tration and muscle regeneration,62 and IL-6 knockout mice
display smaller myoﬁbers than wild-type mice 15 days after
CTX-induced muscle injury.62 Furthermore, increases in
UCP1 protein levels in WAT after exercise training or cold ex-
posure are much less pronounced in IL-6 knockout mice,63
while cold-induced UCP1 levels in intrascapular BAT seem
to be unaffected.64 In mice, cancer cachexia-induced UCP1
expression in WAT is largely reduced in IL-6-receptor knock-
out mice.65 In contrast, our results demonstrate that IL-6 is
not required for intramuscular Ucp1 expression after GLY-
induced fatty inﬁltration followed or not by beta 3-adrenergic
agonist treatment. Further studies will be needed to dissect
the roles played by other cytokines and inﬂammatory signals
in the regulation of Ucp1 expression in intramuscular
adipocytes.
Increased Ucp1 expression in skeletal muscle could provide
a new target for the treatment of fatty inﬁltration in muscle
atrophy and sarcopenia. Indeed, we demonstrate that the ca-
pacity to induce intramuscular Ucp1 expression by GLY injec-
tions is maintained in aged mice. It would be also important
to assess intramuscular Ucp1 expression in other models of
atrophy. This will, however, likely require experiments with
additional animal species because fatty inﬁltration is gener-
ally not observed during denervation atrophy66–69 or cancer
cachexia65,70–72 in mice.
In summary, we show that intramuscular Ucp1 expression
can be triggered during skeletal muscle fatty inﬁltration in
an obesity-resistant mouse strain and that FAPs, the
adipocyte precursors residing in skeletal muscle, are able
to differentiate into brown-like adipocytes. Therefore, FAPs
could be a target for therapies promoting a brown
phenotype in intramuscular adipocytes, with potential to
improve the micro-environment of skeletal muscle affected
by fatty inﬁltration.
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